Sulfoximine-substituted trifluoromethylpyrimidine analogs as inhibitors of proline-rich tyrosine kinase 2 (PYK2) show reduced hERG activity
Daniel P. Walker, Michael P. Zawistoski, Molly A. McGlynn, Jian-Cheng Li, Daniel W. Kung, Peter C. Bonnette, Amy Baumann, Leonard Buckbinder, Janet A. Houser, Jason Boer, Anil Mistry, Seungil Han, LiVolume:
19
Année:
2009
Langue:
english
Pages:
6
DOI:
10.1016/j.bmcl.2009.04.093
Fichier:
PDF, 632 KB
english, 2009